These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 869341)

  • 1. [Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)].
    Abeledo Mezquita G; Otero Reigada MC
    An Esp Pediatr; 1977 Feb; 10(2):167-70. PubMed ID: 869341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.
    van Hest R; Baars H; Kik S; van Gerven P; Trompenaars MC; Kalisvaart N; Keizer S; Borgdorff M; Mensen M; Cobelens F
    Clin Infect Dis; 2004 Aug; 39(4):488-96. PubMed ID: 15356811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)].
    Kameda K; Kawabata S; Shirai S
    Kekkaku; 1980 May; 55(5):247-51. PubMed ID: 7412075
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?
    Gordin FM; Cohn DL; Matts JP; Chaisson RE; O'Brien RJ; ; ;
    Clin Infect Dis; 2004 Aug; 39(4):561-5. PubMed ID: 15356822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of a isoniozid-rifompicin drug hepatotoxicity screening technic in tuberculosis therapy].
    Viteau JM; Toulet J; Plonteux G; Abiven M; Bonfante N
    Sem Hop; 1974 Jun; 50(28):1953-9. PubMed ID: 4374748
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 9. Short course chemotherapy for tuberculosis in children.
    Padmini R; Srinivasan S; Nalini P; Mahadevan S
    J Trop Pediatr; 1993 Dec; 39(6):361-4. PubMed ID: 8133559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
    Decroix G; Pujet JC
    Sem Hop; 1973 Jun; 49(30):2219-24. PubMed ID: 4354303
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
    Gendrel D; Nardou M; Mouba JF; Gahouma D; Moussavou A; Boguikouma JB
    Arch Fr Pediatr; 1989 Nov; 46(9):645-8. PubMed ID: 2604523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic hepatitis with isoniazid and rifampin. A meta-analysis.
    Steele MA; Burk RF; DesPrez RM
    Chest; 1991 Feb; 99(2):465-71. PubMed ID: 1824929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Jaundice and rifampicin. Critical study].
    Nebout T; Dhumeaux D; Berthelot P
    Nouv Presse Med; 1974 Mar; 3(12):733-6. PubMed ID: 4836507
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 15. Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.
    Wu JC; Lee SD; Yeh PF; Chan CY; Wang YJ; Huang YS; Tsai YT; Lee PY; Ting LP; Lo KJ
    Gastroenterology; 1990 Feb; 98(2):502-4. PubMed ID: 2295408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitubercular drug-induced liver injuries].
    Guo Y; Cui D
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampin.
    Tsagaropoulou-Stinga H; Mataki-Emmanouilidou T; Karida-Kavalioti S; Manios S
    Pediatr Infect Dis; 1985; 4(3):270-3. PubMed ID: 4000989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversible acute hepatic failure after treatment with association of isoniazide-rifampicin (author's transl)].
    Le Guillou M; L'Henaff F; Boisseau M; Castaing Y; Bourdalle-Badie C
    Sem Hop; 1981 Jun 18-25; 57(25-28):1199-201. PubMed ID: 6266037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis and antitubercular therapy.
    Mahashur AA; Prabhudesai PP
    J Assoc Physicians India; 1991 Aug; 39(8):595-6. PubMed ID: 1814871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.